6Parish CR. Immune response to chemically modified flagellin. I. Induction of antibody tolerance to flagellin by acetoacetylated derivatives of the protein. J Exp Med 1971; 134:1-20.
7Parish CR. Immune response to chemically modified flagellin. II. Evidence for a fundamental relationship between humoral and cell-mediated immunity. J Exp Med 1971; 134:21- 47.
9Liew FY, Parish CR. Lack of a correlation between cell-mediated immunity to the carrier and the carrier-hapten helper effect. JExp Med 1974; 139:779-784.
10Coffman RL. Origins of the T(H)1-T(H)2 model: a personal perspective. Nat lmmuno12006; 7:539-541.
3Horn-Ross P L, Morris J S,Lee M, et al. Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thy-roid Cancer Study[J]. Cancer Epidemiol Biomarkers Prev,2001,10 (9):979-985.
4Damiola F, Byrnes G, Moissonnier M, et al. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belaru- sian children exposed to radiation[J]. Int J Cancer, 2014, 134(7): 1659-1668.
5Saad A G, Kumar S,Ron E,et al. Proliferative activity of humanthy- roid cells in various age groups and its correlation with the risk of thyroid cancer after radiation exposure[J].J Clin Endocrinol Metab, 2006,91 (7):2672-2677.
6Armstrong G T, Stovall M, Robison L L. Long-term effects of ra- diation exposure among adult survivors of childhood cancer: re- sults from the childhood cancer survivor study[J]. Radiat Res, 2010,174(6):840-850.
7Bhatti P, Veiga L H, Ronckes C M, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer sur- vivor study[J]. Radiat Res,2010,174(6):741-752.
8Anand A, Singh K R, Kushuwaha J K, et al. Papillary thyroid can- cer and Hashimoto's thyroiditis: an association less understood [J]. Indian ,) Surg Oncol, 2014, 5(3):199-204.
